Fibrinolytic and fibrinogenolytic effects of acyl urokinase and urokinase combinations in vitro

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Russian journal of bioorganic chemistry

• Publication date

  2006-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1134/S1068162006040042PMID 16909862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator Complex

  2012cited by this paper
• Protease Nexin 1 Is a Potent Urinary Plasminogen Activator Inhibitor in the Presence of Collagen Type IV*

  2002cited by this paper
• Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase)

  2001cited by this paper
• Elements of the Fibrinolytic System

  2001cited by this paper
• Prolonged plasma clot lysis induced by acyl-derivatives of urokinase in vitro

  2000cited by this paper
• Regulation of fibrinolytic activity by localization of inhibitors to fibrin(ogen)

  2000cited by this paper
• Matrix Metalloproteinase System Deficiencies and Matrix Degradation

  1999cited by this paper
• The Plasminogen (Fibrinolytic) System

  1999cited by this paper
• Thrombolytic agents - An updated overview

  1998cited by this paper
• Rearrangements of the Fibrin Network and Spatial Distribution of Fibrinolytic Components during Plasma Clot Lysis

  1996cited by this paper
• A combination of recombinant single-chain urokinase-type plasminogen activator and streptokinase has a synergistic non-fibrin specific action on in vitro clot lysis

  1995cited by this paper
• [The thrombolytic activity of acylated activator complexes of plasmin-streptokinase with different rates of reactivation].

  1991cited by this paper
• Coronary reperfusion studies with pro-urokinase in acute myocardial infarction: evidence for synergism of low dose urokinase.

  1990cited by this paper
• Receptor‐mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI‐1.

  1990cited by this paper
• Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.

  1988cited by this paper
• Synergism of thrombolytic agents: investigational procedures and clinical potential.

  1988cited by this paper
• Plasminogen activator inhibitors--a review.

  1988cited by this paper
• Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.

  1988cited by this paper
• Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.

  1987cited by this paper
• Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activator.

  1987cited by this paper
• Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction.

  1986cited by this paper
• Hypothalamic prolactin: characterization by radioimmunoassay and bioassay and response to hypophysectomy and restraint stress.

  1986cited by this paper
• Comparison of the hypotensive effects of streptokinase-(human) plasmin activator complex and BRL 26921 (p-anisoylated streptokinase-plasminogen activator complex) in the dog after high dose, bolus administration.

  1984cited by this paper
• Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.

  1984cited by this paper
• Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.

  1984cited by this paper
• Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

  1982cited by this paper
• Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy

  1981cited by this paper

• No citing papers are available for this paper.